BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 30133732)

  • 1. Eugenics Redux: "Reproductive Benefit" as a Rationale for Newborn Screening.
    Paul DB
    Hastings Cent Rep; 2018 Jul; 48 Suppl 2():S12-S13. PubMed ID: 30133732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Baby genome screening: paving the way to genetic discrimination?
    Seidel MG
    BMJ; 2017 Jul; 358():j3294. PubMed ID: 28729238
    [No Abstract]   [Full Text] [Related]  

  • 3. What Genomic Sequencing Can Offer Universal Newborn Screening Programs.
    Powell CM
    Hastings Cent Rep; 2018 Jul; 48 Suppl 2(Suppl 2):S18-S19. PubMed ID: 30133725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Legal Dimensions of Genomic Sequencing in Newborn Screening.
    Zacharias RL; Smith ME; King JS
    Hastings Cent Rep; 2018 Jul; 48 Suppl 2():S39-S41. PubMed ID: 30133728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Families' Experiences with Newborn Screening: A Critical Source of Evidence.
    Grob R; Roberts S; Timmermans S
    Hastings Cent Rep; 2018 Jul; 48 Suppl 2():S29-S31. PubMed ID: 30133722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequencing Newborns: A Call for Nuanced Use of Genomic Technologies.
    Johnston J; Lantos JD; Goldenberg A; Chen F; Parens E; Koenig BA;
    Hastings Cent Rep; 2018 Jul; 48 Suppl 2(Suppl 2):S2-S6. PubMed ID: 30133723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ethical and Psychosocial Issues in Whole Genome Sequencing (WGS) for Newborns.
    Lantos JD
    Pediatrics; 2019 Jan; 143(Suppl 1):S1-S5. PubMed ID: 30600264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Commercial Interests, the Technological Imperative, and Advocates: Three Forces Driving Genomic Sequencing in Newborns.
    Pereira S; Clayton EW
    Hastings Cent Rep; 2018 Jul; 48 Suppl 2():S43-S44. PubMed ID: 30133724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using Newborn Sequencing to Advance Understanding of the Natural History of Disease.
    Holm IA
    Hastings Cent Rep; 2018 Jul; 48 Suppl 2():S45-S46. PubMed ID: 30133736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are Parents Really Obligated to Learn as Much as Possible about Their Children's Genomes?
    Johnston J; Juengst E
    Hastings Cent Rep; 2018 Jul; 48 Suppl 2(Suppl 2):S14-S15. PubMed ID: 30133729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. My Diagnostic Odyssey-A Call to Expand Access to Genomic Testing for the Next Generation.
    Michelson J
    Hastings Cent Rep; 2018 Jul; 48 Suppl 2():S32-S34. PubMed ID: 30133734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ethical implications and practical considerations of ethnically targeted screening for genetic disorders: the case of hemoglobinopathy screening.
    Hinton CF; Grant AM; Grosse SD
    Ethn Health; 2011; 16(4-5):377-88. PubMed ID: 21797724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential Uses and Inherent Challenges of Using Genome-Scale Sequencing to Augment Current Newborn Screening.
    Berg JS; Powell CM
    Cold Spring Harb Perspect Med; 2015 Oct; 5(12):. PubMed ID: 26438605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Ethical aspects of neonatal genetic screening].
    Feito Grande L
    Rev Derecho Genoma Hum; 2010; (32):221-41. PubMed ID: 21192438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequencing projects will screen 200,000 newborns for disease.
    Kaiser J
    Science; 2022 Dec; 378(6625):1159. PubMed ID: 36520905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Issues in newborn screening.
    Saxena A
    Genet Test; 2003; 7(2):131-4. PubMed ID: 12885334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lessons for Sequencing from the Addition of Severe Combined Immunodeficiency to Newborn Screening Panels.
    Puck JM
    Hastings Cent Rep; 2018 Jul; 48 Suppl 2(Suppl 2):S7-S9. PubMed ID: 30133735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Managing sickle cell carrier results generated through newborn screening in Ontario: a precedent-setting policy story.
    Hayeems RZ; Moore Hepburn C; Chakraborty P; Odame I; Clarke J; Miller FA; Brown AD
    Genet Med; 2017 Jun; 19(6):625-627. PubMed ID: 27763632
    [No Abstract]   [Full Text] [Related]  

  • 19. Ethical issues with newborn screening in the genomics era.
    Tarini BA; Goldenberg AJ
    Annu Rev Genomics Hum Genet; 2012; 13():381-93. PubMed ID: 22559326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. To know or not to know, disclosure of a newborn carrier screening test result for cystic fibrosis.
    Vernooij-van Langen AM; Reijntjens S; van der Pal SM; Loeber JG; Dompeling E; Dankert-Roelse JE
    Eur J Med Genet; 2013 Apr; 56(4):192-6. PubMed ID: 23352994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.